| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2800063501012 | 6350101 | STUGERON FORTE CAPS 75MG/CAP ΒΤx20 (BLISTERS2x10) | 01.02 | 01.07 | 1.47 |
| 05/2018 | 2800063502019 | 6350201 | STUGERON TAB 25MG/TAB ΒΤx50 (BLISTERS5x10) | 0.97 | 01.02 | 1.41 |
| 05/2018 | 2800063503016 | 6350301 | STUGERON OR.SU.D 75MG/ML FLx20ML | 1.35 | 1.42 | 1.96 |
For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
Cinnarizine inhibits contractions of vascular smooth muscle cells by blocking L-type and T-type voltage gated calcium channels. Cinnarizine has also been implicated in binding to dopamine D2 receptors, histamine H1 receptors, and muscarinic acetylcholine receptors.